Bleeding with menopausal hormone therapy

Martha Hickey, Sweta Agarwal
Best practice & research. Clinical obstetrics & gynaecology · 2008 · vol. 23(1) , pp. 141–149 · doi:10.1016/j.bpobgyn.2008.07.001 · PMID:18977184 · W1972350201
Review OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper examines bleeding patterns associated with menopausal hormone therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Hormone therapy is highly effective for the treatment of menopausal vasomotor symptoms and vaginal dryness, but commonly leads to unscheduled vaginal bleeding and spotting. This frequently leads to invasive investigations to exclude underlying malignancy and is also very unpopular amongst users. In most cases, no pathology is found and the mechanisms underlying this irregular bleeding are poorly understood. Relatively few studies have investigated how combined hormone therapy might cause endometrial breakdown and bleeding. Evidence to date suggests that hormone therapy exposure induces changes in the density, distribution and structure of endometrial vessels, as well as alterations in the stroma, potentially leading to increased production of vasoactive mediators. The mechanisms of bleeding with menopausal hormone therapy seem to differ from those seen during normal menstruation and breakthrough bleeding in users of long-acting progestogen-only contraception.

My notes (saved in your browser only)

MeSH descriptors

Endometrium Estrogen Replacement Therapy Polyps Postmenopause Uterine Hemorrhage Aged Endometrium Endometrium Estrogen Receptor Modulators Estrogen Receptor Modulators Estrogen Replacement Therapy Female Humans Metrorrhagia Metrorrhagia Middle Aged Norpregnenes Norpregnenes Polyps Postmenopause

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (80)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:05:57.285809+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0 · commercial use OK